Arkolith/Insider Trading/CRDF/Form 4

Erlander Mark

Chief Executive Officer, DirectorCardiff Oncology, Inc. (CRDF) · full profile →Form 4 · filed Nov 29, 2022
Net Buying
Open-Market Buys
$14K
Open-Market Sells
$0
Net Open-Market Flow
$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2022Buy(P)10K$1.43$14K24K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-030946) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML